SugenTech's Self-Diagnostic Antigen Rapid Test Kit Approved by German Health Authorities... "Full-Scale Entry into Home Testing Market"

[Asia Economy Reporter Hyunseok Yoo] SuzenTech announced on the 27th that its 'self-diagnostic' COVID-19 antigen rapid test kit has passed the officially recognized 'German Federal Performance Evaluation (PEI)' and obtained approval for personal use from the German health authority (BfArM).

Following Austria, SuzenTech has succeeded in obtaining self-diagnostic approval in Germany, marking its full-scale entry into the overseas 'home testing' market where COVID-19 confirmation can be easily determined at home. The home diagnostic COVID rapid test kits will be sold not only through existing distribution channels such as 'Diasys,' with which contracts were signed last year, but also through specialized pharmacies and online malls where retail distribution is possible.

A SuzenTech official stated, "The previously sold professional-use products applied the 'nasopharyngeal specimen method,' which involves inserting deep into the nasal cavity causing pain, making personal use difficult. The newly approved COVID-19 antigen rapid test kit uses a nasal swab method that collects specimens from a closer part of the nasal cavity, allowing non-professionals to use it easily and conveniently without pain."

He added, "By simply placing the collected specimen into the kit, infection status can be visually determined within 15 minutes, similar to a pregnancy test kit, enabling effective COVID-19 infection detection. Since the formal antigen approval process is underway domestically, conditional personal use approval will be sequentially pursued in Korea as well."

This content was produced with the assistance of AI translation services.